Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-22-024305
Filing Date
2022-05-05
Accepted
2022-05-05 17:49:11
Documents
1
Period of Report
2022-04-06

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4228
  Complete submission text file 0001213900-22-024305.txt   5572
Mailing Address DORFSTRASSE 29 ZUG V8 6300
Business Address DORFSTRASSE 29 ZUG V8 6300 41 41 510 8022
MoonLake Immunotherapeutics (Issuer) CIK: 0001821586 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address DORFSTRASSE 29 ZUG V8 6300
Business Address
Xavier Ramnik (Reporting) CIK: 0001920780 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39630 | Film No.: 22898011